SCHEMBL3496933

SCHEMBL3496933

CCOC1CCCC(=O)N1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.30
AKR1C1 Q04828 1/20 0.30
CRBN Q96SW2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7770725 0.94 CA1 (0.32) CRBN
SCHEMBL28125389 0.88
SCHEMBL525863 0.88
SCHEMBL11509552 0.82 CRBN (0.38) CRBN
SCHEMBL7762508 0.78
SCHEMBL20183030 0.77
SCHEMBL20183036 0.77
SCHEMBL9621737 0.73 GAA (0.37) CRBN
SCHEMBL7522014 0.72 CA1 (0.35) CRBN
SCHEMBL28037791 0.72 CHRM2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2537827-B1 Process for preparing 4-amino-5-hexenoic acid from succinimide TARGEON SAS (FR) 2014-06-11 EP disclosed
EP-2537827-B1 Process for preparing 4-amino-5-hexenoic acid from succinimide TARGEON SAS (FR) 2014-06-11 EP disclosed
US-20130165693-A1 PROCESS FOR PREPARING 4-AMINO-5-HEXENOIC ACID AND INTERMEDIATES THEREOF TARGEON (FR) 2013-06-27 US disclosed
US-20130165693-A1 PROCESS FOR PREPARING 4-AMINO-5-HEXENOIC ACID AND INTERMEDIATES THEREOF TARGEON (FR) 2013-06-27 US disclosed
US-20130165693-A1 PROCESS FOR PREPARING 4-AMINO-5-HEXENOIC ACID AND INTERMEDIATES THEREOF TARGEON (FR) 2013-06-27 US disclosed
EP-2537827-A1 Process for preparing 4-amino-5-hexenoic acid from succinimide Targeon SAS (FR) 2012-12-26 EP disclosed
EP-2537827-A1 Process for preparing 4-amino-5-hexenoic acid from succinimide Targeon SAS (FR) 2012-12-26 EP disclosed
US-7659294-B2 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists MERCK & CO., INC. (US) 2010-02-09 US disclosed
US-20090042954-A1 2-(Aryl)Azacyclylmethyl Carboxylates, Sulfonates, Phosphonates, Phosphinates and Heterocycles as S1p Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-02-12 US disclosed
EP-1804793-A2 2-(ARYL)AZACYCLYLMETHYL CARBOXYLATES, SULFONATES, PHOSPHONATES, PHOSPHINATES AND HETEROCYCLES AS S1P RECEPTOR AGONISTS Merck & Co., Inc. (US) 2007-07-11 EP disclosed
WO-2006047195-A2 2-(ARYL)AZACYCLYLMETHYL CARBOXYLATES, SULFONATES, PHOSPHONATES, PHOSPHINATES AND HETEROCYCLES AS S1P RECEPTOR AGONISTS MERCK & CO., INC. (US) 2006-05-04 WO disclosed
US-4025512-A ANTIDEPRESSANTS ABBOTT LABORATORIES (US) 1977-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165693-A1 PROCESS FOR PREPARING 4-AMINO-5-HEXENOIC ACID AND INTERMEDIATES THEREOF ALOX5, GRIK5, ALOX5AP AKR1C3 498/4885AKR1C1 551/4885CRBN 1788/4885
US-20090042954-A1 2-(Aryl)Azacyclylmethyl Carboxylates, Sulfonates, Phosphonates, Phosphinates and Heterocycles as S1p Receptor Antagonists S1PR1, S1PR3, S1PR5 AKR1C3 1319/4885AKR1C1 1606/4885CRBN 2478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.